AKER Akers Biosciences Inc gains 21% Nov 5, 2021

Posted By: Rajesh Srivastava - Monday, November 08, 2021

Share

& Comment

Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.http://www.priceseries.com/trade/AKER-Akers-Biosciences-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2021101120211105.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.